chugai pharmaceutical co ltd

A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding

The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.

Chugai Opens Sales Office In China Medical City

Chugai has opened an import, sales and marketing subsidiary in China Medical City.

A*STAR Chief Scientist Wins Cancer Research UK Lifetime Achievement Prize

A*STAR Chief Scientist, Professor Sir David Lane is the recipient of the 2012 Cancer Research UK Lifetime Achievement in Cancer Research Prize.

Chugai Pharma Opens $200m Antibody Lab In Singapore

Tokyo-based Chugai Pharmaceutical Co., Ltd. has officially opened a new laboratory in Singapore that will conduct research into new antibody drugs.